---
title: "Kairos Pharma holds annual shareholder meeting, approves reverse stock split authorization"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291336256.md"
description: "Kairos Pharma held its 2026 annual shareholder meeting, ratifying Weinberg & Company as the independent auditor. Shareholders authorized a charter amendment for a reverse stock split ranging from 1-for-3 to 1-for-250, with final terms set by the board. Additionally, they adopted amendments to the 2023 Equity Incentive Plan, adding 5 million shares and an automatic 5% annual increase for ten years."
datetime: "2026-06-30T21:20:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291336256.md)
  - [en](https://longbridge.com/en/news/291336256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291336256.md)
generator: "portal-rs"
---

# Kairos Pharma holds annual shareholder meeting, approves reverse stock split authorization

-   Kairos Pharma held its 2026 annual shareholder meeting on June 29, 2026. \* Shareholders ratified Weinberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026. \* Investors authorized a charter amendment allowing a reverse stock split between 1-for-3 and 1-for-250; the board will set any final ratio and timing. \* Shareholders adopted amendments to the 2023 Equity Incentive Plan, adding 5 million shares and an automatic 5% annual increase for 10 years. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031328), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [KAPA.US](https://longbridge.com/en/quote/KAPA.US.md)

## Related News & Research

- [Kairos Pharma Announces 1-for-7 Reverse Stock Split | KAPA Stock News](https://longbridge.com/en/news/296651012.md)
- [Petrolia Noco announces availability of Q2 2026 report](https://longbridge.com/en/news/296871879.md)
- [Axian Telecom releases Q2 2026 results presentation](https://longbridge.com/en/news/296807653.md)
- [NiSource declares Q3 2026 distribution of R$ 1.05 per unit, payable Aug. 26](https://longbridge.com/en/news/296784415.md)
- [Vidac Pharma board member Dr. Max Herzberg sells Vidac Pharma shares for EUR 6,450](https://longbridge.com/en/news/296702900.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**